Real-world Progression-Free Survival and Overall Survival of Palbociclib Plus Endocrine Therapy (ET) in Japanese Patients with Hormone Receptor-Positive/human Epidermal Growth Factor Receptor 2-Negative Advanced Breast Cancer in the First-Line or Second-Line Setting: an Observational Study
Breast Cancer(2024)
Key words
Advanced breast cancer,CDK4/6 inhibitors,Palbociclib,Real-world evidence
AI Read Science
Must-Reading Tree
Example

Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined